Lin Liu 刘林
TitleCited byYear
The mathematics of cancer: integrating quantitative models
PM Altrock, LL Liu, F Michor
Nature Reviews Cancer 15 (12), 730-745, 2015
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
M Janiszewska, L Liu, V Almendro, Y Kuang, C Paweletz, RA Sakr, ...
Nature Genetics 47 (10), 1212-1219, 2015
DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes
L Liu, S De, F Michor
Nature Communications 4, 1502, 2013
Immune escape in breast cancer during in situ to invasive carcinoma transition
CRG Del Alcazar, SJ Huh, MB Ekram, A Trinh, LL Liu, F Beca, X Zi, ...
Cancer Discovery 7 (10), 1098-1115, 2017
Next-generation sequencing of paired tyrosine kinase inhibitor-sensitive and-resistant EGFR mutant lung cancer cell lines identifies spectrum of DNA changes associated with …
P Jia, H Jin, CB Meador, J Xia, K Ohashi, L Liu, V Pirazzoli, KB Dahlman, ...
Genome Research 23 (9), 1434-1445, 2013
Multi-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study
Q Liu, H Zhou, L Liu, X Chen, R Zhu, Z Cao
BMC Bioinformatics 12 (1), 294, 2011
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers
HA Yu, C Sima, D Feldman, LL Liu, B Vaitheesvaran, J Cross, CM Rudin, ...
Annals of Oncology 28 (2), 278-284, 2017
mTOR and HDAC inhibitors converge on the TXNIP/thioredoxin pathway to cause catastrophic oxidative stress and regression of RAS-driven tumors
CF Malone, C Emerson, R Ingraham, W Barbosa, S Guerra, H Yoon, ...
Cancer Discovery 7 (12), 1450-1463, 2017
An evolutionary approach for identifying driver mutations in colorectal cancer
J Foo, LL Liu, K Leder, M Riester, Y Iwasa, C Lengauer, F Michor
PLoS Computational Biology 11 (9), e1004350, 2015
Nuclear topology modulates the mutational landscapes of cancer genomes
KS Smith, LL Liu, S Ganesan, F Michor, S De
Nature Structural & Molecular Biology 24 (11), 1000-1006, 2017
Dose-dependent mutation rates determine optimum Erlotinib dosing strategies for EGFR mutant non-small cell lung cancer patients
LL Liu, F Li, W Pao, F Michor
PLoS One 10 (11), e0141665, 2015
GeSICA: Genome segmentation from intra-chromosomal associations
L Liu, Y Zhang, J Feng, N Zheng, J Yin, Y Zhang
BMC Genomics 13 (1), 164, 2012
Probabilistic modeling of reprogramming to induced pluripotent stem cells
LL Liu, J Brumbaugh, O Bar-Nur, Z Smith, M Stadtfeld, A Meissner, ...
Cell Reports 17 (12), 3395-3406, 2016
Adaptive estimation of nonparametric functionals
L Liu, R Mukherjee, JM Robins, E Tchetgen Tchetgen
arXiv preprint arXiv:1608.01364, 2019
Stochastic Evolution of Pancreatic Cancer Metastases During Logistic Clonal Expansion
KN Yamamoto, LL Liu, A Nakamura, H Haeno, F Michor
JCO Clinical Cancer Informatics 3, 1-11, 2019
Efficient estimation of optimal regimes under a no direct effect assumption
L Liu, Z Shahn, JM Robins, A Rotnitzky
arXiv preprint arXiv:1908.10448, 2019
On assumption-free tests and confidence intervals for causal effects estimated by machine learning
L Liu, R Mukherjee, JM Robins
arXiv preprint arXiv:1904.04276, 2019
Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies
KN Yamamoto, A Nakamura, LL Liu, S Stein, AC Tramontano, U Kartoun, ...
PLoS One 14 (4), e0215409, 2019
Dark selection for JAK/STAT-inhibitor resistance in chronic myelomonocytic leukemia
A Kaznatcheev, DR Grimes, R Vander Velde, VL Cannataro, E Baratchart, ...
bioRxiv, 211151, 2017
The system can't perform the operation now. Try again later.
Articles 1–19